NATICK, Mass., Sept. 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate in the Morgan Stanley...
The medical-devices sector has come out swinging against a U.S. Senate proposal that could tap $40 billion from device makers over 10 years to...
(Adds comments from medical-devices group, in the second, fifth and 10th through 12th paragraphs.) By Jon Kamp Of DOW JONES NEWSWIRES...
By Jon Kamp Of DOW JONES NEWSWIRES Medical-devices companies could be asked to contribute $4 billion per year to help cover the tab for U.S...
NATICK, Mass., Sept. 4 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate in the Thomas Weisel...
By Jon Kamp Of DOW JONES NEWSWIRES Boston Scientific Corp. (BSX) backed on Tuesday forecasts for how a 1,820-patient study could expand use of...
Boston Scientific Corp. (BSX) released study results Tuesday that show that implantable cardioverter defibrillators were associated with a 44...
NATICK, Mass. and BARCELONA, Sept. 1 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced long-term data from the...
Results of landmark heart failure trial published by New England Journal of Medicine and presented at ESC NATICK, Mass., and BARCELONA, Spain...
NATICK, Mass., Aug. 27 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced the schedule of the Company's major...
By Jon Kamp Of DOW JONES NEWSWIRES A doctor who succeeded in a patent-infringement battle against Boston Scientific Corp. (BSX) over heart stents...
A federal appeals court on Wednesday revived an earlier patent-infringement ruling about pacemakers against St. Jude Medical Inc. (STJ), but...
A federal appeals court on Wednesday revived an earlier patent infringement ruling about pacemakers against St. Jude Medical Inc. (STJ), possibly...
By Jon Kamp Of DOW JONES NEWSWIRES Final changes to Medicare hospital-reimbursement levels for the upcoming U.S. fiscal year appear slightly...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads